Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

FDA issues complete response letter for Ceftobiprole for treatment of complicated skin infections

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ceftobiprole for the treatment of complicated skin and skin structure infections, including diabetic foot infections.

26 Nov 2008

Study looks at Tamiflu resistance in influenza viruses caused by environmental contamination

The research council FORMAS, Sweden, has granted 5.9 million SEK to a new research project that will study the environmental fate and effects of the anti-viral drug Tamiflu on the development on influenza resistance.

26 Nov 2008

Scribble protein found to be an important regulator of breast cancer

In breast tissue, cells lining the breast's ducts have a certain shape that is required to maintain both organ structure and function.

26 Nov 2008

Scientists reconstruct bat variant of SARS coronavirus

Researchers at the University of North Carolina at Chapel Hill and Vanderbilt University Medical Center have synthetically reconstructed the bat variant of the SARS coronavirus (CoV) that caused the SARS epidemic of 2003.

25 Nov 2008

Selzentry (maraviroc) becomes fully approved HIV antiretrovial

The U.S. Food and Drug Administration (FDA) has granted Selzentry (maraviroc) full (traditional) approval for use in treatment-experienced adults with CCR5-tropic HIV-1 in combination with other antiretrovirals.

25 Nov 2008

Peregrine Pharmaceuticals awarded U.S. patent for anti-viral applications of phospholipid-targeting antibodies

Peregrine Pharmaceuticals, Inc. has announced that the U.S. Patent and Trademark Office has issued U.S. Patent Number No. 7,455,833, which includes broad claims covering anti-viral applications of antibodies that directly bind to aminophospholipids.

25 Nov 2008

Call for greater caution in prescribing inhaled corticosteroids to COPD sufferers

Lung disease experts at Johns Hopkins are calling for physicians to show much greater caution in prescribing inhaled corticosteroid drugs for people with chronic obstructive pulmonary disease after finding evidence that the widely used anti-inflammatory medications increase the risk of pneumonia by a full third.

25 Nov 2008

Dieters could have a harder time fighting flu

In a study published in the November issue of the Journal of Nutrition, Gardner showed that mice with a calorie-restricted diet were more likely to die during the first few days of infection than mice with a normal diet. Caloric restriction is the practice of reducing the intake of calories to 40 percent of a normal diet, while maintaining adequate vitamins and minerals.

25 Nov 2008

Drink tea instead of soft drinks to avoid tooth erosion

Today, the average size soft drink is 20 ounces and contains 17 teaspoons of sugar.

25 Nov 2008

New voice care center

UT Southwestern Medical Center has gathered a team of specially trained physicians and therapists to launch a new center for voice care dedicated to disorders of the voice and larynx.

24 Nov 2008

Researchers develop new strategy for broad spectrum anti-viral drugs

Bavituximab, an anti-viral drug developed by UT Southwestern Medical Center researchers, shows promise as a new strategy to fight viral diseases, including potential bioterrorism agents.

24 Nov 2008

Study shows true economic cost of living with multiple sclerosis

A study of people living with the devastating effects of multiple sclerosis (MS) has shown the true economic cost of living with the incurable, life-long condition.

24 Nov 2008

Live oral Shigella vaccine licensed to PATH

The University of Maryland, Baltimore (UMB) has licensed a pediatric vaccine against Shigella bacteria to PATH, an international nonprofit group, to support clinical trials, with the goal of developing a vaccine suitable for children in resource-poor countries.

24 Nov 2008

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

FDA issues complete response letter for Ceftobiprole for treatment of complicated skin infections

Study looks at Tamiflu resistance in influenza viruses caused by environmental contamination

Scribble protein found to be an important regulator of breast cancer

Scientists reconstruct bat variant of SARS coronavirus

Selzentry (maraviroc) becomes fully approved HIV antiretrovial

Peregrine Pharmaceuticals awarded U.S. patent for anti-viral applications of phospholipid-targeting antibodies

Call for greater caution in prescribing inhaled corticosteroids to COPD sufferers

Dieters could have a harder time fighting flu

Drink tea instead of soft drinks to avoid tooth erosion

New voice care center

Researchers develop new strategy for broad spectrum anti-viral drugs

Study shows true economic cost of living with multiple sclerosis

Live oral Shigella vaccine licensed to PATH

New vaccine principle delivers stronger and faster immune response

Ustekinumab receives positive opinion in Europe for treatment of plaque psoriasis

Evidence of retina self-repair in mammals

Nplate receives positive opinion for marketing authorisation in Europe

Reminder, signs of a heart attack can be subtle

Children born four months before height of cold and flu season have a greater risk of developing childhood asthma

New approach to stopping germs

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in